2m 2m 2m 2m 2m 2m 2m
TSCAN THERAPEUT (TCRX)
NASDAQ
$0.74-$0.008 (-1.08%)
Price as of Aug 03, 2026 12:25 PM EDT- $45.4MMarket Cap
- -54.14%1-Year Change
- BiotechnologyIndustry
TSCAN THERAPEUT (TCRX)
$0.74-$0.008 (-1.08%)
TCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.74 | ||
Change | -$0.01 (-1.68%) | ||
Open | $0.78 | ||
High | $0.78 | ||
Low | $0.73 | ||
Previous Close | $0.76 | ||
Volume | 253,902 | ||
30-Day Average Volume | 840,695 | ||
1-Week Change | -6.42% | ||
1-Month Change | -24.19% | ||
1-Year Change | -54.14% | ||
3-Year Change | -66.83% | ||
5-Year Change | -92.34% | ||
Fundamentals | |||
Shares Outstanding | 61.1M | ||
Total Assets | $202.0M | ||
Market Cap | $45.4M | ||
Enterprise Value | -$50.0M | ||
Period: QTR TTM FY | |||
Revenue | $982,000.00 | ||
Net Income | -$28.7M | ||
Free Cash Flow | -$24.3M | ||
EBIT | -$28.0M | ||
EBITDA | -$27.3M | ||
Net Working Capital | $112.8M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | -51 | ||
P/B | 0 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue